Covered recipient · General Payments record
DELLIS A NORWOOD-GALLOWAY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,816.64
- Reported across 189 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $538.79 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lundbeck LLC | $141.95 | 8 |
| Novo Nordisk AS | $132.79 | 9 |
| Lilly USA, LLC | $76.70 | 4 |
| Otsuka America Pharmaceutical, Inc. | $68.01 | 3 |
| ABBVIE INC. | $59.30 | 2 |
| INTRA-SANA LABORATORIES | $29.37 | 1 |
| PFIZER INC. | $15.83 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.58 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767718 | CMS |
| ABBVIE INC. | $32.72 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103767720 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.84 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101697292 | CMS |
| Intra-Sana Laboratories | $29.37 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138617956 | CMS |
| Lilly USA, LLC | $22.73 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138135 | CMS |
| Lilly USA, LLC | $23.59 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136165390 | CMS |
| Lilly USA, LLC | $14.34 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136138137 | CMS |
| Lilly USA, LLC | $16.04 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140453 | CMS |
| Lundbeck LLC | $19.53 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917083 | CMS |
| Lundbeck LLC | $20.87 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917085 | CMS |
| Lundbeck LLC | $16.17 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917087 | CMS |
| Lundbeck LLC | $15.33 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917089 | CMS |
| Lundbeck LLC | $20.19 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917091 | CMS |
| Lundbeck LLC | $25.88 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917093 | CMS |
| Lundbeck LLC | $8.42 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917095 | CMS |
| Lundbeck LLC | $15.56 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145917097 | CMS |
| Novo Nordisk Inc | $16.19 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991936 | CMS |
| Novo Nordisk Inc | $18.83 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097511313 | CMS |
| Novo Nordisk Inc | $8.03 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097246896 | CMS |
| Novo Nordisk Inc | $20.77 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097722657 | CMS |
| Novo Nordisk Inc | $7.24 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096715315 | CMS |
| Novo Nordisk Inc | $22.07 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096936861 | CMS |
| Novo Nordisk Inc | $6.67 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096639511 | CMS |
| Novo Nordisk Inc | $21.37 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097069937 | CMS |
| Novo Nordisk Inc | $11.62 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097665267 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.78 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118895402 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.89 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118895404 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.34 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118895406 | CMS |
| PFIZER INC. | $15.83 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131526059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.